Zahi Touma

Zahi Touma

Assistant Professor of Medicine
University of Toronto
Clinician-Scientist and Staff Physician
Department of Rheumatology
University Health Network

Dr. Zahi Touma is a rheumatologist, clinician-scientist with the University of Toronto. Dr Touma joined Faculty of the University of Toronto (UoT), Division of Rheumatology as Assistant Professor in March of 2014 and holds School of Graduate Studies appointments.  His research is focused on patients with systemic lupus erythematosus (SLE) and measurement science with a particular interest in the assessment of disease activity, patient reported outcomes and cognitive function. One of his most significant contributions has been the development of the SLE disease activity indices – the SLEDAI Responder Index-50 (S2K RI-50) and SLEDAI-2K Glucocorticoids Index (SGI). He has published 87 peer reviewed original research papers and the majority is focused on the assessment and management of SLE. Dr Touma is a member of the American College of Rheumatology (ACR) subcommittee for the development of classification and response criteria for rheumatic diseases and has recently participated in the development of the new classification criteria for SLE. He is also the co-instructor of the measurement in clinical research course at the Institute of Health Policy, Management and Evaluation (IHPME), UoT. Another major focus of his research is the assessment of cognitive impairment in patients with SLE and its impact on quality of life. He has recently demonstrated with his team the validity of Automatized Neuropsychological Assessment Metrics (ANAM) against the ACR comprehensive neuropsychological battery in the screening for cognitive impairment and developed a composite index to facilitate the interpretability of ANAM results.

Thank you

Your comments are essential for improving the effectiveness of our educational activity. Kindly take a moment to answer this survey. Your CME certificate will be sent to the email ID you will provide in your Personal Information page.

If you have any questions or clarifications, please email us at Thank you!